LANSING, MI – Sparrow patients may have been given a product made by the company whose steroidal medication is believed to be the cause of a deadly fungal meningitis outbreak, officials with the health system said in a press release.
Sparrow did not receive any of the contaminated epidural steroid injections manufactured by the New England Compounding Center (NECC).
But Sparrow, along with more than 3,000 other medical facilities nationwide, received a different product distributed by the same company.
Officials say they are in the process of identifying patients who may have received the medication, although none of the NECC-manufactured medication used at Sparrow has been linked to any illnesses.
“Sparrow has no reason to believe that any of these patients who may have received medication from NECC are at risk for illness,” Brian D. Schroeder, M.D., Senior Vice President and Chief Medical Officer of Sparrow, said in a statement. “We have chosen to proactively take every precaution necessary to ensure the safety, health, and wellness of our patients. Part of that precaution is keeping our patients informed.”
The medication in question was given intravenously, mostly to cardiovascular patients, officials said. Patients experiencing symptoms such as fever, headache, and neck stiffness and who have been notified that they may have received medication from NECC should immediately contact their primary care physician.
If any patients receiving letters have experienced any problems with their treatment, Sparrow recommends they contact their physician or contact Sparrow Pharmacy at 517.364.0742.